{"id":"W2273887450","doi":"10.1200/jco.2000.18.12.2363","title":"Phase I/II Trial of Cyclophosphamide, Mitoxantrone, and Escalated Doses of Carboplatin Supported by Peripheral-Blood Stem Cells in Women With Metastatic Breast Cancer","year":2000,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Mitoxantrone; Carboplatin; Cyclophosphamide; Metastatic breast cancer; Breast cancer; Peripheral blood; Oncology; Internal medicine; Cancer; Chemotherapy; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008852602,0.001323859,0.001521069,0.000323402,0.0002712912,0.0006256126,0.0007563305,0.0009123851,0.003069291],"category_scores_gemma":[0.0006552509,0.0004420159,0.0005576725,0.0003910273,0.0009600061,0.0004710242,0.0002963586,0.0025721,0.0005726978],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008614529,"about_ca_system_score_gemma":0.001093695,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006935635,"about_ca_topic_score_gemma":0.001830874,"domain_scores_codex":[0.9997252,0.0001372839,0.00001431793,0.00004761502,0.00002163748,0.00005395292],"domain_scores_gemma":[0.9996308,0.00007194983,0.00008035636,0.00003124936,0.00001484824,0.0001707371],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7666525,0.05199678,0.008511562,0.0008904784,0.0008468031,0.0003255797,0.0004255633,0.003293954,0.04481576,0.0002718387,0.0037689,0.1182002],"study_design_scores_gemma":[0.6837071,0.2983454,0.009133475,0.00003918127,0.0003108418,0.0002891972,0.00005736191,0.001037676,0.004066597,0.0001422051,0.002857323,0.00001372184],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945664,0.001859063,0.0002633898,0.0003548487,0.00008067857,0.001386422,0.000267179,0.00006725126,0.001154845],"genre_scores_gemma":[0.9905491,0.00184414,0.001637586,0.0006886225,0.0001610786,0.002244174,0.001262669,0.00002046036,0.001592241],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003069291,"threshold_uncertainty_score":0.01026779,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03848341136592249,"score_gpt":0.4150591416245636,"score_spread":0.3765757302586411,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}